{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:33:25Z","timestamp":1775327605275,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":283,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.lrr.2021.100273","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T19:12:06Z","timestamp":1634238726000},"page":"100273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evidence of two different molecular mechanisms as a consequence of an isolated 20q- abnormality in a case of multiple myeloma accompanied with myelodysplastic syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Lubomir","family":"Mitev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2021.100273_bib0001","first-page":"33","article-title":"del(20q) in myeloid malignancies","volume":"5","author":"Bilhou-Nabera","year":"2001","journal-title":"Atlas Genet. Cytogenet. Onco. Haematol"},{"issue":"6","key":"10.1016\/j.lrr.2021.100273_bib0002","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ajh.24347","article-title":"Clinical course of patients with incidental finding of 20q- in the bone marrow without a morphologic evidence of multiple myeloma","volume":"91","author":"Jawad","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2021.100273_bib0003","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.5063.5063","article-title":"Coexistance of multiple myeloma and myelodysplastic syndrome or lymphoid diseasesat diagnosis: evidence for two clonal and independent chromosome abnormalities","volume":"118","author":"Mossafa","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.lrr.2021.100273_bib0004","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cancergen.2012.10.007","article-title":"Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by clg FISH","volume":"205","author":"White","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1016\/j.lrr.2021.100273_bib0005","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.1442.1442","article-title":"Isolated chromosome 20q deletions in patients with non-myeloid disorders","volume":"120","author":"Andrea","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lrr.2021.100273_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/gcc.20078","article-title":"MDS\/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q)","volume":"41","author":"Nilsson","year":"2004","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.lrr.2021.100273_bib0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.leukres.2006.05.018","article-title":"Bortezomib is an effective agent for MDS\/MPD syndrome with 5q- anomaly and thrombocytosis","volume":"31","author":"Terpos","year":"2007","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.lrr.2021.100273_bib0008","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.12710","article-title":"Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact","volume":"164","author":"Bacher","year":"2014","journal-title":"Br. J. Haematol"},{"issue":"8","key":"10.1016\/j.lrr.2021.100273_bib0009","first-page":"230","article-title":"t(14;20)(q32;q12) IGH\/MAFB in plasma cell myeloma","volume":"23","author":"A. Micale","year":"2019","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol"},{"issue":"11","key":"10.1016\/j.lrr.2021.100273_bib0010","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/gcc.20806","article-title":"The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion","volume":"49","author":"Mackinnon","year":"2010","journal-title":"Genes, Chromosom. Cancer"},{"key":"10.1016\/j.lrr.2021.100273_bib0011","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1038\/sj.onc.1208819","article-title":"Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating \u03b2-catenin\/TCFpathway","volume":"24","author":"Wang","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lrr.2021.100273_bib0012","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.febslet.2014.01.046","article-title":"End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinoma","volume":"588","author":"Stypula-Cyrus","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.lrr.2021.100273_bib0013","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1073\/pnas.0611665104","article-title":"Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1016\/j.lrr.2022.100307","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048921000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:11Z","timestamp":1761959291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048921000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":13,"alternative-id":["S2213048921000406"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100273","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of two different molecular mechanisms as a consequence of an isolated 20q- abnormality in a case of multiple myeloma accompanied with myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2021.100273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100273"}}